$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

The Quantified Level of Circulating Prostate Stem Cell Antigen mRNA relative to GAPDH Level Is a Clinically Significant Indictor for Predicting Biochemical Recurrence in Prostate Cancer Patients after Radical Prostatectomy 원문보기

BioMed research international, v.2015, 2015년, pp.292454 -   

Kim, Sung Han (Department of Urology, Center for Prostate Cancer, Research Institute and Hospital of National Cancer Center, Goyang 410-769, Republic of Korea) ,  Park, Weon Seo (Department of Pathology, Center for Prostate Cancer, Research Institute and Hospital of National Cancer Center, Goyang 410-769, Republic of Korea) ,  Lee, Sang Jin (Genitourinary Cancer Branch, Center for Prostate Cancer, Research Institute and Hospital of National Cancer Center, Goyang 410-769, Republic of Korea) ,  Choi, Moon Kyung (Division of Specific Organ Cancer, Center for Prostate Cancer, Research Institute and Hospital of National Cancer Center, Goyang 410-769, Republic of Korea) ,  Yeon, Seung Min (Biometric Research Branch, National Cancer Center, Goyang 410-769, Republic of Korea) ,  Joo, Jeong Nam (Biometric Research Branch, National Cancer Center, Goyang 410-769, Republic of Korea) ,  Ko, Ara (Genitourinary Cancer Branch, Center for Prostate Cancer, Research Institute and Hospital of National Cancer Center, Goyang 410-769, Republic of Korea) ,  Lee, Eun Sik (Department of Urology, Seoul National University Hospital of Medicine,) ,  Joung, Jae Young ,  Seo, Ho Kyung ,  Chung, Jinsoo ,  Lee, Kang Hyun

Abstract ▼ AI-Helper 아이콘AI-Helper

The study quantified the relative absolute PSCA level in relation to the glyceraldehyde 3-phosphate dehydrogenase (GAPDH) level in the peripheral blood of 478 hormone-naive prostate cancer (PC) patients who underwent radical prostatectomy from 2005 to 2012 and evaluated its prognostic significance a...

참고문헌 (23)

  1. 1 Siegel R. Naishadham D. Jemal A. Cancer statistics, 2013 CA: Cancer Journal for Clinicians 2013 63 1 11 30 10.3322/caac.21166 2-s2.0-84872967522 

    상세보기 crossref

  2. 2 Reiter R. E. Gu Z. Watabe T. Prostate stem cell antigen: a cell surface marker overexpressed in prostate cancer Proceedings of the National Academy of Sciences of the United States of America 1998 95 4 1735 1740 10.1073/pnas.95.4.1735 2-s2.0-13144250150 9465086 

    상세보기 crossref

  3. 3 Cunha A. C. Weigle B. Kiessling A. Bachmann M. Rieber E. P. Tissue-specificity of prostate specific antigens: comparative analysis of transcript levels in prostate and non-prostatic tissues Cancer Letters 2006 236 2 229 238 10.1016/j.canlet.2005.05.021 2-s2.0-33646518377 16046056 

    상세보기 crossref

  4. 4 Hara N. Kasahara T. Kawasaki T. Reverse transcription-polymerase chain reaction detection of prostate-specific antigen, prostate-specific membrane antigen, and prostate stem cell antigen in one milliliter of peripheral blood: value for the staging of prostate cancer Clinical Cancer Research 2002 8 6 1794 1799 2-s2.0-0036282360 12060619 

  5. 5 Moore M. L. Teitell M. A. Kim Y. Deletion of PSCA increases metastasis of TRAMP-induced prostate tumors without altering primary tumor formation The Prostate 2008 68 2 139 151 10.1002/pros.20686 2-s2.0-38749113371 18044730 

    상세보기 crossref

  6. 6 Lam J. S. Yamashiro J. Shintaku I. P. Prostate stem cell antigen is overexpressed in prostate cancer metastases Clinical Cancer Research 2005 11 7 2591 2596 10.1158/1078-0432.ccr-04-1842 2-s2.0-17644405097 15814638 

    상세보기 crossref

  7. 7 Han K.-R. Seligson D. B. Liu X. Prostate stem cell antigen expression is associated with gleason score, seminal vesicle invasion and capsular invasion in prostate cancer The Journal of Urology 2004 171 3 1117 1121 10.1097/01.ju.0000109982.60619.93 2-s2.0-1542267902 14767283 

    상세보기 crossref

  8. 8 Schamhart D. Swinnen J. Kurth K.-H. Numeric definition of the clinical performance of the nested reverse transcription-PCR for detection of hematogenous epithelial cells and correction for specific mRNA of non-target cell origin as evaluated for prostate cancer cells Clinical Chemistry 2003 49 9 1458 1466 10.1373/49.9.1458 2-s2.0-0042279269 12928226 

    상세보기 crossref

  9. 9 Zhao Z. Zeng G. Ma W. Ou L. Liang Y. Peripheral blood reverse transcription PCR assay for prostate stem cell antigen correlates with androgen-independent progression in advanced prostate cancer International Journal of Cancer 2012 131 4 902 910 10.1002/ijc.26459 2-s2.0-84862565209 21952944 

    상세보기 crossref

  10. 10 Joung J. Y. Cho K. S. Kim J. E. Prostate stem cell antigen mRNA in peripheral blood as a potential predictor of biochemical recurrence in high-risk prostate cancer Journal of Surgical Oncology 2010 101 2 145 148 10.1002/jso.21445 2-s2.0-76549107118 20039280 

    상세보기 crossref

  11. 11 Joung J. Y. Yang S. O. Jeong I. G. Reverse transcriptase-polymerase chain reaction and immunohistochemical studies for detection of prostate stem cell antigen expression in prostate cancer: potential value in molecular staging of prostate cancer International Journal of Urology 2007 14 7 635 643 10.1111/j.1442-2042.2007.01787.x 2-s2.0-34447538484 17645609 

    상세보기 crossref

  12. 12 Sölétormos G. Semjonow A. Sibley P. E. C. Biological variation of total prostate-specific antigen: a survey of published estimates and consequences for clinical practice Clinical Chemistry 2005 51 8 1342 1351 10.1373/clinchem.2004.046086 2-s2.0-23044467181 15961552 

    상세보기 crossref

  13. 13 Stephan C. Cammann H. Meyer H.-A. Lein M. Jung K. PSA and new biomarkers within multivariate models to improve early detection of prostate cancer Cancer Letters 2007 249 1 18 29 10.1016/j.canlet.2006.12.031 2-s2.0-33947285577 17292541 

    상세보기 crossref

  14. 14 Shariat S. F. Karam J. A. Roehrborn C. G. Blood biomarkers for prostate cancer detection and prognosis Future Oncology 2007 3 4 449 461 10.2217/14796694.3.4.449 2-s2.0-34547903643 17661720 

    상세보기 crossref

  15. 15 Sardana G. Diamandis E. P. Biomarkers for the diagnosis of new and recurrent prostate cancer Biomarkers in Medicine 2012 6 5 587 596 10.2217/bmm.12.72 2-s2.0-84867632836 23075237 

    상세보기 crossref

  16. 16 Ross S. Spencer S. D. Holcomb I. Prostate stem cell antigen as therapy target: tissue expression and in vivo efficacy of an immunoconjugate Cancer Research 2002 62 9 2546 2553 2-s2.0-0036569591 11980648 

    상세보기

  17. 17 Raff A. B. Gray A. Kast W. M. Prostate stem cell antigen: a prospective therapeutic and diagnostic target Cancer Letters 2009 277 2 126 132 10.1016/j.canlet.2008.08.034 18838214 

    상세보기 crossref

  18. 18 Witz I. P. Differential expression of genes by tumor cells of a low or a high malignancy phenotype: the case of murine and human Ly-6 proteins Journal of Cellular Biochemistry. Supplement 2000 77 34 61 66 10.1002/(sici)1097-4644(2000)77:34lt;61::aid-jcb11>3.0.co;2-s 2-s2.0-0034029490 10762016 

    crossref

  19. 19 Rege T. A. Hagood J. S. Thy-1, a versatile modulator of signaling affecting cellular adhesion, proliferation, survival, and cytokine/growth factor responses Biochimica et Biophysica Acta 2006 1763 10 991 999 10.1016/j.bbamcr.2006.08.008 2-s2.0-33749077290 16996153 

    상세보기 crossref

  20. 20 Koie T. Mitsuzuka K. Yoneyama T. Prostate-specific antigen density predicts extracapsular extension and increased risk of biochemical recurrence in patients with high-risk prostate cancer who underwent radical prostatectomy International Journal of Clinical Oncology 2015 20 1 176 181 10.1007/s10147-014-0696-0 24771079 

    상세보기 crossref

  21. 21 Yossepowitch O. Briganti A. Eastham J. A. Positive surgical margins after radical prostatectomy: a systematic review and contemporary update European Urology 2014 65 2 303 313 10.1016/j.eururo.2013.07.039 2-s2.0-84891833099 23932439 

    상세보기 crossref

  22. 22 Punnen S. Cooperberg M. R. D'Amico A. V. Management of biochemical recurrence after primary treatment of prostate cancer: a systematic review of the literature European Urology 2013 64 6 905 915 10.1016/j.eururo.2013.05.025 2-s2.0-84887402225 23721958 

    상세보기 crossref

  23. 23 Zhigang Z. Wenlu S. The association of prostate stem cell antigen (PSCA) mRNA expression and subsequent prostate cancer risk in men with benign prostatic hyperplasia following transurethral resection of the prostate The Prostate 2008 68 2 190 199 10.1002/pros.20701 2-s2.0-38749100205 18076024 

    상세보기 crossref
LOADING...

관련 콘텐츠

오픈액세스(OA) 유형

GOLD

오픈액세스 학술지에 출판된 논문

이 논문과 함께 이용한 콘텐츠

저작권 관리 안내
섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로